首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1297783

全球医疗保健分析测试服务市场 - 2023-2030年

Global Healthcare Analytical Testing Services Market - 2023-2030

出版日期: 2023年06月15日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球医疗保健分析测试服务市场在2022年达到64亿美元，预计到2030年将见证有利可图的增长，达到147亿美元。在预测期内（2023-2030年），全球医疗保健分析测试服务市场预计将呈现11.1%的复合增长率。

医疗保健分析测试服务通过进行测试来识别潜在的风险，确保医疗设备、药品和其他保健产品的质量和功效，从而帮助保障病人的安全。这些测试有助于识别污染物，验证产品的完整性，并检测任何可能对病人构成威胁的有害物质。

检测服务有助于评估不同治疗方式的有效性。临床试验和研究依靠分析测试来衡量治疗效果，评估药物在体内的浓度，并评估疾病进展或治疗反应的生物标志物。

市场动态

实验室检测服务外包的趋势将推动市场增长

由于实验室检测服务外包趋势的上升，各公司正通过提供各种服务和解决方案来扩大其市场份额。主要的参与者也在专注于其他战略，包括合併、收购和其他进展。

例如，2021年8月，为了扩大其在日本的测试产品范围，欧陆集团与Noritsu Koki有限公司签订了一份合同。由于生物分析测试服务至关重要，该市场预计将迅速增长。因此，知名企业的扩张战略促进了市场的增长。

传染性疾病发病率的增加将推动市场的增长

登革热、艾滋病毒等传染病发病率的增加将推动市场的增长。例如，根据世界卫生组织的数据，登革热病毒（DENV）感染了叮咬人的蚊子，导致了被称为登革热的病毒感染。现在世界上大约有一半的人口面临着登革热的风险，据认为每年会有1-5亿人感染。登革热是一种热带和亚热带疾病，主要影响城市和半城市环境。尽管由于传染病在增加，它必须在实验室进行分析，但医疗分析测试服务的市场将在未来几年扩大。

数据不安全将阻碍市场的增长。

解决医疗分析测试服务中的数据不安全问题需要一个多方面的方法，包括强大的网络安全措施、定期安全评估、员工培训和遵守相关法规。对医疗机构来说，投资于保护病人数据并在面对不断变化的网络威胁时保持警惕是至关重要的。因此，上述因素限制了市场的增长。

COVID-19影响分析

COVID-19大流行病对医疗分析测试服务产生了重大影响。它导致了测试需求的增加，加速了新测试方法和技术的采用，使实验室资源紧张，并重新调整了优先事项。尽管有这些挑战，大流行病也刺激了创新和合作，推动了测试方法的进步以及自动化和人工智能与医疗分析测试服务的整合。

俄乌战争影响分析

俄罗斯-乌克兰冲突估计对全球医疗分析测试服务市场的影响不大，因为该地区的主要市场参与者数量较少。然而，在预测期内，原材料进出口的影响预计对全球医疗保健分析测试服务市场的增长影响不大。

人工智能影响分析

人工智能驱动的算法可以非常精确地分析医疗图像，如X射线、CT扫描和MRI。深度学习算法可以检测出人类专家可能难以识别的异常情况、病变和模式。这有助于放射科医生做出准确的诊断，减少错误，并改善病人的治疗效果。人工智能在医疗保健分析测试服务方面具有显著优势，从数据分析和解释到预测分析、图像分析、基因组分析、药物发现、质量控制和工作流程优化。

Market Overview

The Global Healthcare Analytical Testing Services Market reached US$ 6.4 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 14.7 billion by 2030. The global Healthcare Analytical Testing Services Market is expected to exhibit a CAGR of 11.1% during the forecast period (2023-2030).

Healthcare analytical testing services help safeguard patient safety by conducting tests to identify potential risks and ensure the quality and efficacy of medical devices, pharmaceuticals, and other healthcare products. These tests help identify contaminants, verify product integrity, and detect any harmful substances that could pose a threat to patients.

Testing services contribute to evaluating the effectiveness of different treatment modalities. Clinical trials and studies rely on analytical testing to measure treatment outcomes, assess drug concentrations in the body, and evaluate biomarkers of disease progression or treatment response.

Market Dynamics

Rising Trend of Outsourcing Laboratory Testing Services Will Drive The Market Growth

Companies are growing their market share by providing a variety of services and solutions as a result of the rising trend of outsourcing laboratory testing services. Major players are also concentrating on other strategies, including mergers, acquisitions, and other advances.

For instance, in August 2021, to increase the scope of its testing offerings in Japan, Eurofins Scientific entered into a contract with Noritsu Koki Co. Ltd to purchase GeneTech Inc., a major participant in genetic analysis in Japan.The market is expected to increase rapidly since the bioanalytical testing service is crucial. Therefore, prominent players' expanding strategies contribute to the growth of the market.

Increasing Prevalence Of Infectious Diseases Will Drive The Market Growth

The increasing prevalence of infectious diseases like dengue, HIV and others will drive the market growth. For instance, according to WHO, the dengue virus (DENV), which infects mosquitoes that bite people, causes the viral infection known as dengue. Approximately half of the world's population is now at risk for dengue, with 100-500 million infections thought to occur annually. Dengue is a tropical and subtropical disease that primarily affects urban and semi-urban settings. Although it must be analyzed in laboratories since infectious diseases are on the rise, the market for healthcare analytical testing services will expand in the next years.

Data Insecurity Will Hamper The Market Growth.

Addressing data insecurity in healthcare analytical testing services requires a multi-faceted approach involving robust cybersecurity measures, regular security assessments, employee training, and compliance with relevant regulations. It is crucial for healthcare organizations to invest in the protection of patient data and stay vigilant in the face of evolving cyber threats. Thus above factors restrict the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on healthcare analytical testing services. It led to increased testing demand, accelerated the adoption of new testing methods and technologies, strained laboratory resources, and reshaped priorities. Despite the challenges, the pandemic also spurred innovation and collaboration, driving advancements in testing methodologies and the integration of automation and AI into healthcare analytical testing services.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global Healthcare Analytical Testing Services market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global Healthcare Analytical Testing Servicesmarket growth over the forecast period.

Artificial Intelligence Impact Analysis

AI-powered algorithms can analyze medical images, such as X-rays, CT scans, and MRIs, with remarkable precision. Deep learning algorithms can detect anomalies, lesions, and patterns that might be difficult for human experts to identify. This assists radiologists in making accurate diagnoses, reducing errors, and improving patient outcomes. AI offers significant advantages in healthcare analytical testing services, ranging from data analysis and interpretation to predictive analytics, image analysis, genomic analysis, drug discovery, quality control, and workflow optimization.

Segment Analysis

The global healthcare analytical testing servicesmarket is segmented based on test type, end user and region.

Pharmaceutical & Biopharmaceutical Companies from End user Segment Accounts for 38.3% of Market Share.

The strategies of the key players will dominate the segment's growth. For instance, on October 24, 2022, as part of its $97 million expansion, Thermo Fisher added a clinical research facility.

The business establishes a bioanalytical lab in the US, adding 59,000 square feet of additional space to the facility overall, making it "one of the largest laboratories of its kind." The new bioanalytical facility is part of a $97 million (€99 million) total investment that Thermo Fisher will make at the Richmond, Virginia, location. The lab will be utilized to offer laboratory services in the drug development process, the company claims. As a result, market growth will be dominated by key players' company expansion and collaboration.

Geographical Analysis

Asia Pacific Accounted for Approximately 25.4% of the Market Share

Due to increased investments made in improving regional analytical services by businesses from developed economies, changes made to evaluation standards by regulatory bodies to bring them into line with international standards, and the creation of new facilities and alliances to expand the reach of their offerings to different regions in the region.

For instance, on May 19, 2021, Leading global life sciences company announced the addition of bioanalytical services in Singapore to its drug development offering in the Asia-Pacific region. And Singapore is a significant region for bolstering Labcorp's vast global presence because it provides clients of the company with a complementary site to support their bioanalytical research, both domestically and internationally.

Additionally, August 04, 2021, TetraQ has been acquired by Agilex Biolabs as part of its APAC expansion plans. Agilex Biolabs specialises in the bioanalysis of biologics and small compounds for PK, immunogenicity, biomarker, and immunological pharmacodynamics assessments. With its knowledgeable workforce and decades of experience in regulated bioanalytical services, TetraQ complements the work of Agilex Biolabs in Australia and the APAC region. Thus, the aforementioned variables predominate market growth.

Competitive Landscape

The major global players in the healthcare analytical testing services market include: Pharmaceutical Product Development, LLC (PPD), Eurofins Scientific, SGS SA, Toxikon Inc., Pace Analytical Services, Intertek Pharmaceutical Services, Boston Analytical, West Pharmaceutical Services Inc., Steris, Charles River Laboratories and among others.

Why Purchase the Report?

To visualize the global healthcare analytical testing services market segmentation based on test type, end user and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of Healthcare Analytical Testing Services market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global Healthcare Analytical Testing Services market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Test Type
3.2. Snippet by End User
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising clinical trials will drive the market growth
  - 4.1.1.2. Increasing growth for bioanalytical testing services
- 4.1.2. Restraints
  - 4.1.2.1. Data Insecurity will hamper the market growth
- 4.1.3. Opportunity
  - 4.1.3.1. The increasing focus on preventive healthcare and early disease detection
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. Artificial Intelligence Impact

8. ByTest Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 8.1.2. Market Attractiveness Index, By Test Type
8.2. Bioanalytical Testing Services*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Method Development & Validation
8.4. Stability Testing
8.5. Drug Substances
8.6. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Pharmaceutical & Biopharmaceutical Companies*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Medical Device Companies
9.4. Contract Research Organizations
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.5.1. The U.S.
  - 10.2.5.2. Canada
  - 10.2.5.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.5.1. Germany
  - 10.3.5.2. The U.K.
  - 10.3.5.3. France
  - 10.3.5.4. Spain
  - 10.3.5.5. Italy
  - 10.3.5.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.5.1. Brazil
  - 10.4.5.2. Argentina
  - 10.4.5.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.5.1. China
  - 10.5.5.2. India
  - 10.5.5.3. Japan

Australia

10.5.5.4. Rest of Asia-Pacific

10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Pharmaceutical Product Development, LLC (PPD)*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Eurofins Scientific
12.3. SGS SA
12.4. Toxikon Inc.
12.5. Pace Analytical Services
12.6. Intertek Pharmaceutical Services
12.7. Boston Analytical
12.8. West Pharmaceutical Services Inc.
12.9. Steris
12.10. Charles River Laboratories.

LIST NOT EXHAUSTIVE

13. Appendix

13.1. About Us and Services
13.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球医疗保健分析测试服务市场 - 2023-2030年

Global Healthcare Analytical Testing Services Market - 2023-2030

市场概况

市场动态

实验室检测服务外包的趋势将推动市场增长

传染性疾病发病率的增加将推动市场的增长

数据不安全将阻碍市场的增长。

COVID-19影响分析

俄乌战争影响分析

人工智能影响分析

目录

第一章：方法和范围

第二章：定义和概述

第三章：执行摘要

第四章：动态变化

第五章：行业分析

第六章：COVID-19分析

第7章 ：人工智能的影响

第八章：按测试类型划分

第九章：按终端用户分类

第十章：按地区划分

第11章 ：竞争格局

第十二章 ：公司简介

第十三章 ：附录